NEW!
BASIC AND CLINICAL PHARMACOLOGY 15TH
MR MR MR MR
EDITION KATZUNG TREVOR TEST BANK
MR MR MR MR MR
INCLUSIVE MROF MRCHAPTERS MR1-66 MRCOMPLETE MRWITH MREXPLAINED MRANSWERS
, Page MR2 MRof MR822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
MR MR MR MR MR MR MR MR
Bank
M R
Chapter MR1. MRIntroduction: MRThe MRNature MRof MRDrugs MR& MRDrug MRDevelopment MR& MRRegulation
1. A MRnurse MRworking MRin MRradiology MRadministers MRiodine MRto MRa MRpatient
MRwho MRis MRhaving MRa MRcomputed MRtomography MR(CT) MRscan. MRThe MRnurse
MRworking MRon MRthe MRoncology MRunit MRadministers MRchemotherapy MRto
MRpatients MRwho MRhave MRcancer. MRAt MRthe MRPublic MRHealth MRDepartment, MRa
MRnurse MRadministers MRa MRmeasles-mumps-rubella MR(MMR) MRvaccine MRto MRa
MR14-month-old MRchild MRas MRa MRroutine MRimmunization. MRWhich MRbranch MRof
MRpharmacology MRbest MRdescribes MRthe MRactions MRof MRall MRthree M R nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology MRis MRthe MRstudy MRof MRthe MRbiologic MReffects MRof MRchemicals.
MRNurses MRare MRinvolved MRwith MRclinical MRpharmacology MRor
MRpharmacotherapeutics, MRwhich MRis MRa MRbranch MRof MRpharmacology MRthat
MRdeals MRwith MRthe MRuses MRof MRdrugs MRto MRtreat, MRprevent, MRand MRdiagnose
MRdisease. MRThe MRradiology MRnurse MRis MRadministering MRa MRdrug MRto MRhelp
MRdiagnose MRa MRdisease. MRThe MRoncology MRnurse MRis MRadministering MRa MRdrug
MRto MRhelp MRtreat MRa MRdisease. MRPharmacoeconomics MRincludes MRany MRcosts
MRinvolved MRin MRdrug MRtherapy.
Pharmacodynamics MRinvolves MRhow MRa MRdrug MRaffects MRthe MRbody MRand
MRpharmacokinetics MRis MRhow MRthe MRbody MRacts MRon MRthe MRbody.
2. When MRinvolved MRin MRphase MRIII MRdrug MRevaluation
MRstudies, MRwhat MRresponsibilities MRwould MRthe MRnurse
MRhave?
A) Working MRwith MRanimals MRwho MRare MRgiven MRexperimental MR drugs
B) Choosing MRappropriate MRpatients MRto MRbe MRinvolved MRin MRthe MRdrug M R study
C) Monitoring MRand MRobserving MRpatients MRclosely MRfor MRadverse M R effects
,D) Conducting MRresearch MRto MRdetermine MReffectiveness MRof MRthe M R drug
Page MR3 MRof MR822
Ans: C
Feedback:
Phase MRIII MRstudies MRinvolve MRuse MRof MRa MRdrug MRin MRa MRvast MRclinical
MRpopulation MRin MRwhich MRpatients MRare MRasked MRto MRrecord MRany MRsymptoms
MRthey MRexperience MRwhile MRtaking MRthe MRdrugs. MRNurses MRmay MRbe
MRresponsible MRfor MRhelping MRcollect MRand MRanalyze MRthe MRinformation MRto
MRbe MRshared MRwith MRthe MRFood MRand MRDrug MRAdministration MR(FDA) MRbut
MRwould MRnot MRconduct MRresearch MRindependently MRbecause MRnurses MRdo MRnot
MRprescribe MRmedications. MRUse MRof MRanimals MRin MRdrug MRtesting MRis MRdone
MRin MRthe MRpreclinical MRtrials. MRSelect MRpatients MRwho MRare MRinvolved MRin
MRphase MRII MRstudies MRto MRparticipate MRin MRstudies MRwhere MRthe MRparticipants
MRhave MRthe MRdisease MRthe MRdrug MRis MRintended MRto MRtreat. MRThese MRpatients
MRare MRmonitored MRclosely MRfor MRdrug MRaction MRand MRadverse MReffects.
MRPhase MRI MRstudies MRinvolve MRhealthy MRhuman MRvolunteers MRwho MRare
MRusually MRpaid MRfor MRtheir MRparticipation. MRNurses MRmay MRobserve MRfor
MRadverse MReffects MRand MRtoxicity.
3. A MRphysician MRhas MRordered MRintramuscular MR(IM) MRinjections MRof
MRmorphine, MRa MRnarcotic, MRevery MR4 MRhours MRas MRneeded MRfor MRpain MRin MRa
MRmotor MRvehicle MRaccident MRvictim. MRThe MRnurse MRis MRaware MRthis MRdrug
MRhas MRa MRhigh MRabuse MRpotential. MRUnder MRwhat MRcategory MRwould
MRmorphine MRbe MRclassified?
A) Schedule MRI
B) Schedule MRII
C) Schedule MRIII
D) Schedule MRIV
Ans: B
Feedback:
, Narcotics MRwith MRa MRhigh MRabuse MRpotential MRare MRclassified MRas MRSchedule
MRII MRdrugs MRbecause MRof MRsevere MRdependence MRliability. MRSchedule MRI
MRdrugs MRhave MRhigh MRabuse MRpotential MRand MRno MRaccepted MRmedical MRuse.
MRSchedule MRIII MRdrugs MRhave MRa MRlesser MRabuse MRpotential MRthan MRII MRand
MRan MRaccepted MRmedical MRuse. MRSchedule MRIV MRdrugs MRhave MRlow MRabuse
MRpotential MRand MRlimited MRdependence MRliability.
4. What MRconcept MRis MRconsidered MRwhen MRgeneric MRdrugs MRare MRsubstituted
MRfor MRbrand MRname MRdrugs?
A) Bioavailability
Page MR4 MRof MR822 Ans: D
Feedback:
B) Critical MRconcentration It MRis MRimportant MRfor MRthe MRnurse MRto MRspec
MRover-the-counter MRmedications MRbecause M
C) Distribution
MRthem MRimportant. MRThe MRpatient MRis MRunlik
D) Half-life MRof MRorphan MRdrugs MRunless MRthey MRtoo MRar
MRSafety MRduring MRpregnancy, MRuse MRof MRa MR
Ans: A
MRclassification MRof MRorphan MRdrugs MRare MRth
Feedback: MRunable MRto MRanswer MRbut MRcould MRbe MRfoun
MRnurse MRwishes MRto MRresearch MRthem.
Bioavailability MRis MRthe MRportion MRof MRa MRdose MRof MRa MRdrug MRthat MRreaches
MRthe MRsystemic MRcirculation MRand MRis MRavailable MRto MRact MRon MRbody MRcells.
MRBinders MRused MRin MRa MRgeneric MRdrug MRmay MRnot MRbe MRthe MRsame MRas
MRthose MRused MRin MRthe MRbrand MRname MRdrug. MRTherefore, MRthe MRway MRthe
MRbody MRbreaks MRdown MRand MRuses MRthe MRdrug MRmay MRdiffer, MRwhich MRmay
MReliminate MRa MRgeneric MRdrug MRsubstitution. MRCritical MRconcentration MRis MRthe
MRamount MRof MRa MRdrug MRthat MRis MRneeded MRto MRcause MRa MRtherapeutic MReffect
MRand MRshould MRnot MRdiffer MRbetween MRgeneric MRand MRbrand MRname
MRmedications. MRDistribution MRis MRthe MRphase MRof MRpharmacokinetics,
MRwhich MRinvolves MRthe MRmovement MRof MRa MRdrug MRto MRthe MRbodys MRtissues
MRand MRis MRthe MRsame MRin MRgeneric MRand MRbrand MRname MRdrugs. MRA MRdrugs
MRhalf-life MRis MRthe MRtime MRit MRtakes MRfor MRthe MRamount MRof MRdrug MRto
MRdecrease MRto MRhalf MRthe MRpeak MRlevel, MRwhich MRshould MRnot MRchange
MRwhen MRsubstituting MRa MRgeneric M R medication.
5. A MRnurse MRis MRassessing MRthe MRpatients MRhome MRmedication MRuse. MRAfter
MRlistening MRto MRthe MRpatient MRlist MRcurrent MRmedications, MRthe MRnurse MRasks
MRwhat MRpriority MRquestion?
A) Do MRyou MRtake MRany MRgeneric MRmedications?
B) Are MRany MRof MRthese MRmedications MRorphan MRdrugs?
C) Are MRthese MRmedications MRsafe MRto MRtake MRduring MRpregnancy?
D) Do MRyou MRtake MRany MRover-the-counter MRmedications?
BASIC AND CLINICAL PHARMACOLOGY 15TH
MR MR MR MR
EDITION KATZUNG TREVOR TEST BANK
MR MR MR MR MR
INCLUSIVE MROF MRCHAPTERS MR1-66 MRCOMPLETE MRWITH MREXPLAINED MRANSWERS
, Page MR2 MRof MR822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
MR MR MR MR MR MR MR MR
Bank
M R
Chapter MR1. MRIntroduction: MRThe MRNature MRof MRDrugs MR& MRDrug MRDevelopment MR& MRRegulation
1. A MRnurse MRworking MRin MRradiology MRadministers MRiodine MRto MRa MRpatient
MRwho MRis MRhaving MRa MRcomputed MRtomography MR(CT) MRscan. MRThe MRnurse
MRworking MRon MRthe MRoncology MRunit MRadministers MRchemotherapy MRto
MRpatients MRwho MRhave MRcancer. MRAt MRthe MRPublic MRHealth MRDepartment, MRa
MRnurse MRadministers MRa MRmeasles-mumps-rubella MR(MMR) MRvaccine MRto MRa
MR14-month-old MRchild MRas MRa MRroutine MRimmunization. MRWhich MRbranch MRof
MRpharmacology MRbest MRdescribes MRthe MRactions MRof MRall MRthree M R nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology MRis MRthe MRstudy MRof MRthe MRbiologic MReffects MRof MRchemicals.
MRNurses MRare MRinvolved MRwith MRclinical MRpharmacology MRor
MRpharmacotherapeutics, MRwhich MRis MRa MRbranch MRof MRpharmacology MRthat
MRdeals MRwith MRthe MRuses MRof MRdrugs MRto MRtreat, MRprevent, MRand MRdiagnose
MRdisease. MRThe MRradiology MRnurse MRis MRadministering MRa MRdrug MRto MRhelp
MRdiagnose MRa MRdisease. MRThe MRoncology MRnurse MRis MRadministering MRa MRdrug
MRto MRhelp MRtreat MRa MRdisease. MRPharmacoeconomics MRincludes MRany MRcosts
MRinvolved MRin MRdrug MRtherapy.
Pharmacodynamics MRinvolves MRhow MRa MRdrug MRaffects MRthe MRbody MRand
MRpharmacokinetics MRis MRhow MRthe MRbody MRacts MRon MRthe MRbody.
2. When MRinvolved MRin MRphase MRIII MRdrug MRevaluation
MRstudies, MRwhat MRresponsibilities MRwould MRthe MRnurse
MRhave?
A) Working MRwith MRanimals MRwho MRare MRgiven MRexperimental MR drugs
B) Choosing MRappropriate MRpatients MRto MRbe MRinvolved MRin MRthe MRdrug M R study
C) Monitoring MRand MRobserving MRpatients MRclosely MRfor MRadverse M R effects
,D) Conducting MRresearch MRto MRdetermine MReffectiveness MRof MRthe M R drug
Page MR3 MRof MR822
Ans: C
Feedback:
Phase MRIII MRstudies MRinvolve MRuse MRof MRa MRdrug MRin MRa MRvast MRclinical
MRpopulation MRin MRwhich MRpatients MRare MRasked MRto MRrecord MRany MRsymptoms
MRthey MRexperience MRwhile MRtaking MRthe MRdrugs. MRNurses MRmay MRbe
MRresponsible MRfor MRhelping MRcollect MRand MRanalyze MRthe MRinformation MRto
MRbe MRshared MRwith MRthe MRFood MRand MRDrug MRAdministration MR(FDA) MRbut
MRwould MRnot MRconduct MRresearch MRindependently MRbecause MRnurses MRdo MRnot
MRprescribe MRmedications. MRUse MRof MRanimals MRin MRdrug MRtesting MRis MRdone
MRin MRthe MRpreclinical MRtrials. MRSelect MRpatients MRwho MRare MRinvolved MRin
MRphase MRII MRstudies MRto MRparticipate MRin MRstudies MRwhere MRthe MRparticipants
MRhave MRthe MRdisease MRthe MRdrug MRis MRintended MRto MRtreat. MRThese MRpatients
MRare MRmonitored MRclosely MRfor MRdrug MRaction MRand MRadverse MReffects.
MRPhase MRI MRstudies MRinvolve MRhealthy MRhuman MRvolunteers MRwho MRare
MRusually MRpaid MRfor MRtheir MRparticipation. MRNurses MRmay MRobserve MRfor
MRadverse MReffects MRand MRtoxicity.
3. A MRphysician MRhas MRordered MRintramuscular MR(IM) MRinjections MRof
MRmorphine, MRa MRnarcotic, MRevery MR4 MRhours MRas MRneeded MRfor MRpain MRin MRa
MRmotor MRvehicle MRaccident MRvictim. MRThe MRnurse MRis MRaware MRthis MRdrug
MRhas MRa MRhigh MRabuse MRpotential. MRUnder MRwhat MRcategory MRwould
MRmorphine MRbe MRclassified?
A) Schedule MRI
B) Schedule MRII
C) Schedule MRIII
D) Schedule MRIV
Ans: B
Feedback:
, Narcotics MRwith MRa MRhigh MRabuse MRpotential MRare MRclassified MRas MRSchedule
MRII MRdrugs MRbecause MRof MRsevere MRdependence MRliability. MRSchedule MRI
MRdrugs MRhave MRhigh MRabuse MRpotential MRand MRno MRaccepted MRmedical MRuse.
MRSchedule MRIII MRdrugs MRhave MRa MRlesser MRabuse MRpotential MRthan MRII MRand
MRan MRaccepted MRmedical MRuse. MRSchedule MRIV MRdrugs MRhave MRlow MRabuse
MRpotential MRand MRlimited MRdependence MRliability.
4. What MRconcept MRis MRconsidered MRwhen MRgeneric MRdrugs MRare MRsubstituted
MRfor MRbrand MRname MRdrugs?
A) Bioavailability
Page MR4 MRof MR822 Ans: D
Feedback:
B) Critical MRconcentration It MRis MRimportant MRfor MRthe MRnurse MRto MRspec
MRover-the-counter MRmedications MRbecause M
C) Distribution
MRthem MRimportant. MRThe MRpatient MRis MRunlik
D) Half-life MRof MRorphan MRdrugs MRunless MRthey MRtoo MRar
MRSafety MRduring MRpregnancy, MRuse MRof MRa MR
Ans: A
MRclassification MRof MRorphan MRdrugs MRare MRth
Feedback: MRunable MRto MRanswer MRbut MRcould MRbe MRfoun
MRnurse MRwishes MRto MRresearch MRthem.
Bioavailability MRis MRthe MRportion MRof MRa MRdose MRof MRa MRdrug MRthat MRreaches
MRthe MRsystemic MRcirculation MRand MRis MRavailable MRto MRact MRon MRbody MRcells.
MRBinders MRused MRin MRa MRgeneric MRdrug MRmay MRnot MRbe MRthe MRsame MRas
MRthose MRused MRin MRthe MRbrand MRname MRdrug. MRTherefore, MRthe MRway MRthe
MRbody MRbreaks MRdown MRand MRuses MRthe MRdrug MRmay MRdiffer, MRwhich MRmay
MReliminate MRa MRgeneric MRdrug MRsubstitution. MRCritical MRconcentration MRis MRthe
MRamount MRof MRa MRdrug MRthat MRis MRneeded MRto MRcause MRa MRtherapeutic MReffect
MRand MRshould MRnot MRdiffer MRbetween MRgeneric MRand MRbrand MRname
MRmedications. MRDistribution MRis MRthe MRphase MRof MRpharmacokinetics,
MRwhich MRinvolves MRthe MRmovement MRof MRa MRdrug MRto MRthe MRbodys MRtissues
MRand MRis MRthe MRsame MRin MRgeneric MRand MRbrand MRname MRdrugs. MRA MRdrugs
MRhalf-life MRis MRthe MRtime MRit MRtakes MRfor MRthe MRamount MRof MRdrug MRto
MRdecrease MRto MRhalf MRthe MRpeak MRlevel, MRwhich MRshould MRnot MRchange
MRwhen MRsubstituting MRa MRgeneric M R medication.
5. A MRnurse MRis MRassessing MRthe MRpatients MRhome MRmedication MRuse. MRAfter
MRlistening MRto MRthe MRpatient MRlist MRcurrent MRmedications, MRthe MRnurse MRasks
MRwhat MRpriority MRquestion?
A) Do MRyou MRtake MRany MRgeneric MRmedications?
B) Are MRany MRof MRthese MRmedications MRorphan MRdrugs?
C) Are MRthese MRmedications MRsafe MRto MRtake MRduring MRpregnancy?
D) Do MRyou MRtake MRany MRover-the-counter MRmedications?
